AR046641A1 - Uso del (+)-(2s, 3s)-2-(3-clorofenil)-3,5,5-trimetil-2-morfolinol - Google Patents
Uso del (+)-(2s, 3s)-2-(3-clorofenil)-3,5,5-trimetil-2-morfolinolInfo
- Publication number
- AR046641A1 AR046641A1 ARP040104268A ARP040104268A AR046641A1 AR 046641 A1 AR046641 A1 AR 046641A1 AR P040104268 A ARP040104268 A AR P040104268A AR P040104268 A ARP040104268 A AR P040104268A AR 046641 A1 AR046641 A1 AR 046641A1
- Authority
- AR
- Argentina
- Prior art keywords
- morpholinol
- chlorophenyl
- trimethyl
- treatment
- restless legs
- Prior art date
Links
- RCOBKSKAZMVBHT-TVQRCGJNSA-N radafaxine Chemical compound C[C@@H]1NC(C)(C)CO[C@@]1(O)C1=CC=CC(Cl)=C1 RCOBKSKAZMVBHT-TVQRCGJNSA-N 0.000 title abstract 2
- 208000005793 Restless legs syndrome Diseases 0.000 abstract 2
- 208000016285 Movement disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- ABCGFHPGHXSVKI-UHFFFAOYSA-O meso-tetrakis(n-methyl-4-pyridyl)porphine(4+) Chemical compound C1=C[N+](C)=CC=C1C(C1=CC=C(N1)C(C=1C=C[N+](C)=CC=1)=C1C=CC(=N1)C(C=1C=C[N+](C)=CC=1)=C1C=CC(N1)=C1C=2C=C[N+](C)=CC=2)=C2N=C1C=C2 ABCGFHPGHXSVKI-UHFFFAOYSA-O 0.000 abstract 1
- 230000000737 periodic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0327195.4A GB0327195D0 (en) | 2003-11-21 | 2003-11-21 | Novel use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR046641A1 true AR046641A1 (es) | 2005-12-14 |
Family
ID=29764268
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040104268A AR046641A1 (es) | 2003-11-21 | 2004-11-19 | Uso del (+)-(2s, 3s)-2-(3-clorofenil)-3,5,5-trimetil-2-morfolinol |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20070142378A1 (https=) |
| EP (1) | EP1684765A1 (https=) |
| JP (1) | JP2007511577A (https=) |
| AR (1) | AR046641A1 (https=) |
| GB (1) | GB0327195D0 (https=) |
| TW (1) | TW200529858A (https=) |
| WO (1) | WO2005053700A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0425445D0 (en) * | 2004-11-18 | 2004-12-22 | Smithkline Beecham Corp | Novel compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL193622B1 (pl) * | 1998-01-21 | 2007-02-28 | Glaxo Group Ltd | Farmaceutycznie czynny morfolinol, zawierająca gokompozycja oraz jego zastosowanie |
| US7098206B2 (en) * | 1998-01-21 | 2006-08-29 | Smithkline Beecham Corporation | Pharmaceutically active morpholinol |
| US6337328B1 (en) * | 1999-03-01 | 2002-01-08 | Sepracor, Inc. | Bupropion metabolites and methods of use |
| US6342496B1 (en) * | 1999-03-01 | 2002-01-29 | Sepracor Inc. | Bupropion metabolites and methods of use |
| EP1336406A1 (en) * | 2002-02-14 | 2003-08-20 | Solvay Pharmaceuticals B.V. | Partial dopamine-D2 receptor agonist plus serotonin and/or noradrenaline inhibitory activity |
-
2003
- 2003-11-21 GB GBGB0327195.4A patent/GB0327195D0/en not_active Ceased
-
2004
- 2004-11-19 WO PCT/EP2004/013248 patent/WO2005053700A1/en not_active Ceased
- 2004-11-19 JP JP2006540363A patent/JP2007511577A/ja active Pending
- 2004-11-19 TW TW093135507A patent/TW200529858A/zh unknown
- 2004-11-19 AR ARP040104268A patent/AR046641A1/es unknown
- 2004-11-19 EP EP04803222A patent/EP1684765A1/en not_active Withdrawn
- 2004-11-19 US US10/595,885 patent/US20070142378A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007511577A (ja) | 2007-05-10 |
| US20070142378A1 (en) | 2007-06-21 |
| GB0327195D0 (en) | 2003-12-24 |
| WO2005053700A1 (en) | 2005-06-16 |
| EP1684765A1 (en) | 2006-08-02 |
| TW200529858A (en) | 2005-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1113108T1 (el) | Μεσυλικο προφαρμακου λεβοντοπα, συνθεσεις αυτου, και χρησεις αυτου | |
| ECSP088763A (es) | Nuevas combinaciones terapéuticas para el tratamiento de la depresión | |
| DE60336664D1 (de) | Nichtnukleosidische reverse-transkriptase-hemmer | |
| CY1118179T1 (el) | Φαρμακευτικη συνθεση | |
| CY1110965T1 (el) | Επιπροσθετες ετεροπολυκυκλικες ενωσεις και η χρηση τους ως ανταγωνιστες μεταβολοτροπικου υποδοχεα γλουταμικου | |
| RU2010129238A (ru) | Применение производных изотиоцианата в качестве противомиеломных средств | |
| CY1106589T1 (el) | (s)-2-ν-προπυλαμινο-5-υδροξυτετραλινη ως d3-αγωνιστικο θεραπευτικο μεσο | |
| CY1107419T1 (el) | Προφαρμακα αντι-ιικων μεσων απο πιπεραζινη και υποκατεστημενη πιπεριδινη | |
| ECSP088329A (es) | Nuevos diazaespiroalcanos y su uso para el tratamiento de enfermedades mediadas por ccr8 | |
| AR051405A1 (es) | Compuestos de 2-carboxamido(3-amino)tiofeno | |
| EA200801138A1 (ru) | Применение флибансерина для лечения расстройств полового влечения в предклимактерический период | |
| UY29796A1 (es) | Nuevos compuestos para el tratamiento de trastornos neurológicos, psiquiátricos o del dolor | |
| CY1112738T1 (el) | Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη | |
| CY1110130T1 (el) | Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α. | |
| AR109263A2 (es) | Composición que comprende moxidectina | |
| UY28098A1 (es) | Derivados de anilinopirazol útiles en el tratamiento de la diabetes | |
| AR077139A1 (es) | Composiciones farmaceuticas utiles para tratar el vch | |
| AR077138A1 (es) | Composiciones farmaceuticas utiles para tratar el vhc | |
| UY27018A1 (es) | Derivados de la pirimidina | |
| BRPI0417858A (pt) | composto, composição farmacêutica, e, uso de uma composição farmacêutica | |
| SE0302546D0 (sv) | New compounds | |
| EA200501821A1 (ru) | Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат | |
| ECSP045397A (es) | 6-ALQUILIDEN-PENEMS BICÍCLICOS COMO INHIBIDORES DE LAS b-LACTAMASAS | |
| CR10255A (es) | "nuevas composiciones terapéuticas para el tratamiento o la prevención de trastornos psicóticos" | |
| GT200600409A (es) | Uso de agomelatina para obtener medicamentos propuestos para el tratamiento de trastornos del sueño en el paciente deprimido. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |